cohort 4 limited Company Information
Company Number
08900579
Next Accounts
Dec 2024
Industry
Specialist medical practice activities
Shareholders
-
Group Structure
View All
Contact
Registered Address
scout hall 164 long street, atherstone, CV9 1AE
Website
www.cohort4.org.ukcohort 4 limited Estimated Valuation
Pomanda estimates the enterprise value of COHORT 4 LIMITED at £83.2k based on a Turnover of £184k and 0.45x industry multiple (adjusted for size and gross margin).
cohort 4 limited Estimated Valuation
Pomanda estimates the enterprise value of COHORT 4 LIMITED at £0 based on an EBITDA of £-15.9k and a 3.4x industry multiple (adjusted for size and gross margin).
cohort 4 limited Estimated Valuation
Pomanda estimates the enterprise value of COHORT 4 LIMITED at £107.9k based on Net Assets of £42.5k and 2.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cohort 4 Limited Overview
Cohort 4 Limited is a live company located in atherstone, CV9 1AE with a Companies House number of 08900579. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in February 2014, it's largest shareholder is unknown. Cohort 4 Limited is a established, micro sized company, Pomanda has estimated its turnover at £184k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cohort 4 Limited Health Check
Pomanda's financial health check has awarded Cohort 4 Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £184k, make it smaller than the average company (£500.7k)
- Cohort 4 Limited
£500.7k - Industry AVG
Growth
3 year (CAGR) sales growth of 85%, show it is growing at a faster rate (5.4%)
- Cohort 4 Limited
5.4% - Industry AVG
Production
with a gross margin of 31.6%, this company has a higher cost of product (55.4%)
- Cohort 4 Limited
55.4% - Industry AVG
Profitability
an operating margin of -8.6% make it less profitable than the average company (14.4%)
- Cohort 4 Limited
14.4% - Industry AVG
Employees
with 2 employees, this is below the industry average (13)
- Cohort 4 Limited
13 - Industry AVG
Pay Structure
on an average salary of £29.5k, the company has an equivalent pay structure (£29.5k)
- Cohort 4 Limited
£29.5k - Industry AVG
Efficiency
resulting in sales per employee of £92k, this is more efficient (£69.4k)
- Cohort 4 Limited
£69.4k - Industry AVG
Debtor Days
it gets paid by customers after 73 days, this is later than average (31 days)
- Cohort 4 Limited
31 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Cohort 4 Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Cohort 4 Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Cohort 4 Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.3%, this is a lower level of debt than the average (30.8%)
1.3% - Cohort 4 Limited
30.8% - Industry AVG
COHORT 4 LIMITED financials
Cohort 4 Limited's latest turnover from March 2023 is estimated at £184 thousand and the company has net assets of £42.5 thousand. According to their latest financial statements, we estimate that Cohort 4 Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | |||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | |||||||||
Tax | |||||||||
Profit After Tax | |||||||||
Dividends Paid | |||||||||
Retained Profit | |||||||||
Employee Costs | |||||||||
Number Of Employees | |||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 4,390 | 8,937 | 5,382 | 1,817 | 2,322 | 3,338 | 3,023 | 2,598 | 801 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 4,390 | 8,937 | 5,382 | 1,817 | 2,322 | 3,338 | 3,023 | 2,598 | 801 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 36,919 | 48,278 | 46,367 | 8,176 | 12,968 | 9,166 | 3,544 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 1,750 | 1,750 | 1,750 | 1,750 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,121 | 18,486 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 38,669 | 50,028 | 48,117 | 9,926 | 12,968 | 9,166 | 3,544 | 3,121 | 18,486 |
total assets | 43,059 | 58,965 | 53,499 | 11,743 | 15,290 | 12,504 | 6,567 | 5,719 | 19,287 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 3,903 | 1,153 | 0 | 207 | 3,123 | 2,312 | 2,805 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 3,903 | 1,153 | 0 | 207 | 3,123 | 2,312 | 2,805 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 550 | 550 | 550 | 500 | 500 | 500 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 550 | 550 | 550 | 500 | 500 | 500 | 0 | 0 | 0 |
total liabilities | 550 | 550 | 4,453 | 1,653 | 500 | 707 | 3,123 | 2,312 | 2,805 |
net assets | 42,509 | 58,415 | 49,046 | 10,090 | 14,790 | 11,797 | 3,444 | 3,407 | 16,482 |
total shareholders funds | 42,509 | 58,415 | 49,046 | 10,090 | 14,790 | 11,797 | 3,444 | 3,407 | 16,482 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | |||||||||
Depreciation | 1,298 | 401 | |||||||
Amortisation | 0 | 0 | |||||||
Tax | |||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -11,359 | 1,911 | 38,191 | -3,042 | 3,802 | 5,622 | 3,544 | 0 | 0 |
Creditors | 0 | -3,903 | 2,750 | 1,153 | -207 | -2,916 | 811 | -493 | 2,805 |
Accruals and Deferred Income | 0 | 0 | 50 | 0 | 0 | 500 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||
interest | |||||||||
cash flow from financing | |||||||||
cash and cash equivalents | |||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | -3,121 | -15,365 | 18,486 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -3,121 | -15,365 | 18,486 |
cohort 4 limited Credit Report and Business Information
Cohort 4 Limited Competitor Analysis
Perform a competitor analysis for cohort 4 limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in CV9 area or any other competitors across 12 key performance metrics.
cohort 4 limited Ownership
COHORT 4 LIMITED group structure
Cohort 4 Limited has no subsidiary companies.
Ultimate parent company
COHORT 4 LIMITED
08900579
cohort 4 limited directors
Cohort 4 Limited currently has 4 directors. The longest serving directors include Mrs Beverley Gilbert (Feb 2014) and Mrs Rachel Wilde (Aug 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Beverley Gilbert | England | 57 years | Feb 2014 | - | Director |
Mrs Rachel Wilde | England | 31 years | Aug 2016 | - | Director |
Ms Maria Beale | United Kingdom | 50 years | Apr 2019 | - | Director |
Mrs Julia Goodall | England | 75 years | Jun 2023 | - | Director |
P&L
March 2023turnover
184k
-4%
operating profit
-15.9k
0%
gross margin
31.6%
-9.86%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
42.5k
-0.27%
total assets
43.1k
-0.27%
cash
0
0%
net assets
Total assets minus all liabilities
cohort 4 limited company details
company number
08900579
Type
Private Ltd By Guarantee w/o Share Cap
industry
86220 - Specialist medical practice activities
incorporation date
February 2014
age
10
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
scout hall 164 long street, atherstone, CV9 1AE
Bank
-
Legal Advisor
-
cohort 4 limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cohort 4 limited.
cohort 4 limited Companies House Filings - See Documents
date | description | view/download |
---|